| HGNC Family | Killer cell immunoglobulin-like receptors (KIR), Immunoglobulin superfamily domain containing |
| Name | killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1 |
| Description | Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several `framework` genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2013] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nKIR3DS1 is a conserved activating receptor expressed on natural killer (NK) cells that, despite being encoded in a locus also containing inhibitory KIR3DL1 alleles, is reliably detectable on fresh circulating NK cells. Experimental transfection studies have demonstrated that surface expression of KIR3DS1 depends on its association with the adaptor protein DAP12, and population analyses indicate that its sequence has been maintained by balancing selection alongside inhibitory counterparts."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFunctional studies in the context of viral infections have shown that KIR3DS1-expressing NK cells are endowed with enhanced antiviral effector potential. In vitro experiments using HIV-1 target cells expressing the putative ligand HLA-Bw4‐80I demonstrate that NK cells carrying KIR3DS1 exhibit marked, dose‐ and cell–contact–dependent inhibition of viral replication, along with increased secretion of interferon-γ. These observations underscore the receptor’s role in promoting early antiviral responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond baseline antiviral functions, the KIR3DS1 receptor appears to contribute to the dynamic adaptation of the NK-cell compartment during acute viral infections. In acute HIV-1 infection, for instance, expansion of NK cells expressing KIR3DS1 has been observed, suggesting that the receptor may help tailor immune responses to rapidly evolving viral challenges. In the setting of hematopoietic stem cell transplantation for hematological malignancies, donor KIR3DS1 positivity correlates with a reduction in acute graft-versus-host disease, implicating the receptor in modulating the balance between beneficial graft-versus-tumor effects and deleterious alloreactivity. Moreover, during cytomegalovirus (CMV) infection, KIR3DS1—along with other activating KIRs—contributes to the clonal-like expansion of NK cells, further supporting its role in antiviral immunity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent data have also extended the functional relevance of KIR3DS1 to hepatitis C virus (HCV) infection. In well‐designed cell culture models, humanized mice, and primary liver tissues derived from individuals with HCV, the ligand HLA-F is up-regulated on infected cells, and engagement of KIR3DS1 with HLA-F appears to potentiate NK cell–mediated antiviral control. This finding opens avenues to develop strategies that promote KIR3DS1/HLA-F interactions to enhance immune defenses against chronic viral infections and possibly malignancies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Anita Trundley, Helge Frebel, Des Jones, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/eji.200636773"}], "href": "https://doi.org/10.1002/eji.200636773"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17301953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17301953"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Paul J Norman, Laurent Abi-Rached, Ketevan Gendzekhadze, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng2111"}], "href": "https://doi.org/10.1038/ng2111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17694054"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17694054"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Galit Alter, Maureen P Martin, Nickolas Teigen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20070695"}], "href": "https://doi.org/10.1084/jem.20070695"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18025129"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18025129"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Brian R Long, Lishomwa C Ndhlovu, Jorge R Oksenberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.02449-07"}], "href": "https://doi.org/10.1128/JVI.02449-07"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18305035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18305035"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Roberto Díaz-Peña, Miguel Angel Blanco-Gelaz, Beatriz Suárez-Alvarez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activating KIR genes are associated with ankylosing spondylitis in Asian populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Immunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humimm.2008.04.012"}], "href": "https://doi.org/10.1016/j.humimm.2008.04.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18638658"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18638658"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Galit Alter, Suzannah Rihn, Katharine Walter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.00256-09"}], "href": "https://doi.org/10.1128/JVI.00256-09"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19386717"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19386717"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jeffrey M Venstrom, Ted A Gooley, Stephen Spellman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2009-08-236943"}], "href": "https://doi.org/10.1182/blood-2009-08-236943"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20124216"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20124216"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Vivien Béziat, Lisa L Liu, Jenny-Ann Malmberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2012-10-459545"}], "href": "https://doi.org/10.1182/blood-2012-10-459545"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23325834"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23325834"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Sebastian Lunemann, Anja Schöbel, Janine Kah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2018.07.019"}], "href": "https://doi.org/10.1053/j.gastro.2018.07.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30031767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30031767"}]}]}]}
|
| Synonyms | KIR-G1, NKAT-10, CD158E2, KIR-123FM, NKAT10 |
| Proteins | KI3S1_HUMAN |
| NCBI Gene ID | 3813 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
KIR3DS1 has 702 functional associations with biological entities spanning 7 categories (organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 34 datasets.
Click the + buttons to view associations for KIR3DS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by KIR3DS1 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of KIR3DS1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of KIR3DS1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of KIR3DS1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with KIR3DS1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with KIR3DS1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| GAD Gene-Disease Associations | diseases associated with KIR3DS1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with KIR3DS1 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with KIR3DS1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing KIR3DS1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of KIR3DS1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of KIR3DS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of KIR3DS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of KIR3DS1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving KIR3DS1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving KIR3DS1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving KIR3DS1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing KIR3DS1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by KIR3DS1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by KIR3DS1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by KIR3DS1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for KIR3DS1 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with KIR3DS1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for KIR3DS1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of KIR3DS1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate KIR3DS1 protein from the curated KEA Substrates of Kinases dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain KIR3DS1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for KIR3DS1 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving KIR3DS1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving KIR3DS1 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving KIR3DS1 protein from the Reactome Pathways 2024 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of KIR3DS1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of KIR3DS1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of KIR3DS1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |